Intellia Therapeutics (NTLA) PT Lowered to $86 at SVB Leerink
Tweet
Share
E-mailGet Alerts NTLA Hot Sheet
Price: $11.90 -1.57%
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Join SI Premium – FREE
SVB Leerink analyst Mani Foroohar lowered the price target on Intellia Therapeutics (NASDAQ: NTLA) to $86.00 (from $90.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Macquarie Upgrades Inventec Corp (2356:TT) to Neutral
- JPMorgan Upgrades KCE Electronics PCL (KCE:TB) to Overweight
- HOYA Corporation (7741:JP) (HOCPF) PT Raised to JPY30,600 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
